Silexion Therapeutics Corp is a biotechnology company focused on developing innovative therapies to address unmet medical needs in various therapeutic areas
The company specializes in the discovery and advancement of novel drug candidates utilizing its proprietary technologies. With a commitment to improving patient outcomes, Silexion aims to leverage cutting-edge research and development to create targeted treatments that enhance the quality of life for individuals suffering from complex diseases. Through collaboration with academic institutions and industry partners, Silexion strives to bring transformative healthcare solutions to market.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Silexion's SIL204 reduced tumor growth and metastases in pancreatic cancer models, showing strong efficacy across KRAS mutation profiles in preclinical studies.
Biotech remains a high-risk, high-reward sector, and this month’s top draws reflect retail’s appetite for stocks with major clinical and regulatory catalysts.
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
